Hap Trading, LLC Myovant Sciences Ltd. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$24.03 - $27.02 $36,045 - $40,530	-1,500 Reduced 3.34%	43,400 $321,000
Q3 2022 Nov 14, 2022	BUY	$11.6 - $20.44 $184,440 - $324,996	15,900 Added 54.83%	44,900 $120,000
Q2 2022 Aug 12, 2022	BUY	$7.78 - $14.69 $35,010 - $66,105	4,500 Added 18.37%	29,000 $42,000
Q1 2022 May 12, 2022	BUY	$11.38 - $16.4 $278,810 - $401,799	24,500 New	24,500 $59,000
Q2 2021 Aug 11, 2021	SELL	$17.07 - $24.56 $209,961 - $302,088	-12,300 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$20.46 - $25.18 $8,184 - $10,072	-400 Reduced 3.15%	12,300 $16,000
Q3 2020 Nov 13, 2020	BUY	$14.05 - $22.6 $25,290 - $40,680	1,800 Added 16.51%	12,700 $5,000
Q2 2020 Aug 10, 2020	BUY	$7.34 - $20.84 $80,006 - $227,156	10,900 New	10,900 $47,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.